However, among others, CHD6, DNAJB2 and NNMT, known to be associated with aberrant TP53 expression and high tumor progression53–55, showed a differential abundance comparing TP53-mutated to TP53-wildtype cases. This evidence concerns the gene TP53 and neoplasm.